UBS raised the firm’s price target on RXO Inc. (RXO) to $15 from $14 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO, Inc.: Hold Rating Maintained Amid Stable Outlook and Modest Growth Expectations
- RXO, Inc.: Balancing Profitability Amid Market Challenges with a Hold Rating
- RXO, Inc. Reports Strong Q2 Performance Amid Market Challenges
- RXO, Inc. Hold Rating: Strong LTL and Last Mile Performance Amid TL Challenges and Uncertain Outlook
- RXO Reports Q2 2025 Financial Results with Revenue Growth